Stocktoria
Design Therapeutics, Inc. DSGN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-03-26
Design Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 2,722,754 | $29.0M |
| BlackRock Finance, Inc. | 2,304,948 | $7.7M |
| D. E. Shaw & Co., Inc. | 470,270 | $5.0M |
| RENAISSANCE TECHNOLOGIES LLC | 408,200 | $4.3M |
| CITADEL ADVISORS LLC | 231,513 | $2.5M |
| MILLENNIUM MANAGEMENT LLC | 108,928 | $1.2M |
| AQR CAPITAL MANAGEMENT LLC | 25,957 | $276,184 |
| TWO SIGMA INVESTMENTS, LP | 16,300 | $173,432 |
Source: SEC EDGAR filings · CIK 0001807120 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.